trans-Complementation of HBV rtM204I mutant replication by HBV wild-type polymerase.

about

trans-Complementation of HBV rtM204I mutant replication by HBV wild-type polymerase.

Item

http://www.wikidata.org/entity/Q36897030

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

trans-Complementation of HBV rtM204I mutant replication by HBV wild-type polymerase.

@en

type

Item

label

trans-Complementation of HBV rtM204I mutant replication by HBV wild-type polymerase.

@en

prefLabel

trans-Complementation of HBV rtM204I mutant replication by HBV wild-type polymerase.

@en

P1476

trans-Complementation of HBV rtM204I mutant replication by HBV wild-type polymerase.

@en

P2093

Harriet C Isom

http://www.w3.org/2001/XMLSchema#string

Jason L Starkey

http://www.w3.org/2001/XMLSchema#string

Jianming Hu

http://www.w3.org/2001/XMLSchema#string

Richard A Heipertz

http://www.w3.org/2001/XMLSchema#string

Thomas G Miller

http://www.w3.org/2001/XMLSchema#string

P2860

The enigmatic X gene of hepatitis B virus

Telbivudine versus lamivudine in patients with chronic hepatitis B

Long-term follow-up of patients with anti-HBe/HBV DNA-positive chronic hepatitis B treated for 12 months with lamivudine

Fulminant hepatic failure resulting from lamivudine-resistant hepatitis B virus in a renal transplant recipient: durable response after orthotopic liver transplantation on adefovir dipivoxil and hepatitis B immune globulin

Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen

Lamivudine. A review of its therapeutic potential in chronic hepatitis B.

The duck hepatitis B virus polymerase is activated by its RNA packaging signal, epsilon.

YMDD motif in hepatitis B virus DNA polymerase influences on replication and lamivudine resistance: A study by in vitro full-length viral DNA transfection.

Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV DNA.

Comparison of anti-hepatitis B virus activities of lamivudine and clevudine by a quantitative assay.

P304

57-67

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.VIROL.2009.03.018

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

388

http://www.w3.org/2001/XMLSchema#string

P577

2009-04-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24345731

http://www.w3.org/2001/XMLSchema#string

P698

19383566

http://www.w3.org/2001/XMLSchema#string

P932

3670753

http://www.w3.org/2001/XMLSchema#string